# Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

> **NCT03425058** · — · COMPLETED · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 80 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03425058
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-22
- **Primary completion:** 2020-02-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03425058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03425058, "Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03425058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*